Exchange: NASDAQ·Updated 07:43 PM EDT

BLLN Billiontoone Inc. - Ordinary Shares - Class A

$94.86
$1.91
(2.01%)
Today
Closed $93.24
$1.62
(1.74%)
After Hours
Reported EarningsAug 5
Mkt Cap$4.4B
Vol423,156.00

About BLLN

BillionToOne, Inc. is a next-generation molecular diagnostics company on a mission to create powerful and accurate tests that are accessible to all. Its patented Quantitative Counting Templates (QCT) molecular counting platform is a multiplex technology capable of accurately counting DNA molecules at the single-molecule level. The was founded by Oguzhan Atay, Sukrit Silas, and David Tsao in 2016 and is headquartered in Menlo Park, CA.
38

Bearish Sentiment

How do you feel about BLLN?

Advertisement|Remove ads.